Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03024216
Title Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients Who Have Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Hawaii
Indications

prostate adenocarcinoma

Therapies

Atezolizumab + Sipuleucel-T

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.